InnerScope Hearing Technologies, Inc. (INND) Research

InnerScope Hearing Technologies, Inc. specializes in delivering a variety of hearing solutions, primarily supplying the retail hearing aid community with its array of hearing aids and personal sound amplification devices, available in both hearable and wearable forms. The company's operations encompass the manufacturing and direct-to-consumer distribution and sales of these devices. Beyond hardware, InnerScope also offers a suite of related products and services, which include hearing-related therapeutic treatments, physician-developed dietary supplements aimed at supporting hearing health, and a unique CBD oil specifically formulated for managing tinnitus. Expanding its comprehensive approach, InnerScope manages and operates eleven audiological and retail hearing device clinics. Additionally, it provides a business-to-business (B2B) software-as-a-service (SaaS) platform for patient management. Founded in 2012 as Innerscope Advertising Agency, Inc., the company officially adopted its current name, InnerScope Hearing Technologies, Inc., in August 2017, and its corporate headquarters are located in Roseville, California.

Market snapshot

Symbol
INND
Price
$0.00
Day change
+100.00%
Market cap
$613.0
P/E ratio
-0.21x
52-week range
0.0001-0.0056
Sector
Healthcare
Industry
Medical - Instruments & Supplies

Peer companies

  • Aida Pharmaceuticals, Inc. (AIDA)
  • Better Therapeutics, Inc. (BTTX)
  • Inyx, Inc. (IYXI)
  • Lancer Orthodontics, Inc. (LANZ)
  • MJ Holdings, Inc. (MJNE)
  • MedSmart Group Inc. (MSGP)
  • Oncology Pharma Inc. (ONPH)
  • SpectraScience, Inc. (SCIE)

Recent insider activity

  • Moore Matthew Ross — S-Sale (2500 shares) on 2017-03-15
  • Moore Matthew Ross — S-Sale (2500 shares) on 2017-03-17
  • Moore Matthew Ross — trade (0 shares) on 2017-02-22
  • Moore Matthew Ross — trade (0 shares) on 2017-02-22
  • Moore Mark Lee — trade (0 shares) on 2017-02-22

Open InnerScope Hearing Technologies, Inc. (INND) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.